80 related articles for article (PubMed ID: 25757674)
1. Reply to Wang and Sadée.
Henderson G; Bullmore ET
Psychopharmacology (Berl); 2015 Apr; 232(8):1495-6. PubMed ID: 25757674
[No Abstract] [Full Text] [Related]
2. Response to paper by Kelly et al "The opioid receptor pharmacology of GSK1521498 compared to other ligands with different effects on compulsive reward-related behaviors" published in Psychopharmacology 232, 305-314, 2014.
Wang D; Sadee W
Psychopharmacology (Berl); 2015 Apr; 232(8):1493-4. PubMed ID: 25740344
[No Abstract] [Full Text] [Related]
3. Lessons learned from using fMRI in the early clinical development of a mu-opioid receptor antagonist for disorders of compulsive consumption.
Nathan PJ; Bakker G
Psychopharmacology (Berl); 2021 May; 238(5):1255-1263. PubMed ID: 31900526
[TBL] [Abstract][Full Text] [Related]
4. The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice.
Ripley TL; Sanchez-Roige S; Bullmore ET; Mugnaini M; Maltby K; Miller SR; Wille DR; Nathan P; Stephens DN
Psychopharmacology (Berl); 2015 Sep; 232(18):3431-41. PubMed ID: 26141191
[TBL] [Abstract][Full Text] [Related]
5. Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist.
Ignar DM; Goetz AS; Noble KN; Carballo LH; Stroup AE; Fisher JC; Boucheron JA; Brainard TA; Larkin AL; Epperly AH; Shearer TW; Sorensen SD; Speake JD; Hommel JD
J Pharmacol Exp Ther; 2011 Oct; 339(1):24-34. PubMed ID: 21712426
[TBL] [Abstract][Full Text] [Related]
6. Opioid receptor modulation of hedonic taste preference and food intake: a single-dose safety, pharmacokinetic, and pharmacodynamic investigation with GSK1521498, a novel μ-opioid receptor inverse agonist.
Nathan PJ; O'Neill BV; Bush MA; Koch A; Tao WX; Maltby K; Napolitano A; Brooke AC; Skeggs AL; Herman CS; Larkin AL; Ignar DM; Richards DB; Williams PM; Bullmore ET
J Clin Pharmacol; 2012 Apr; 52(4):464-74. PubMed ID: 21610207
[TBL] [Abstract][Full Text] [Related]
7. Blockade of patch-based μ opioid receptors in the striatum attenuates methamphetamine-induced conditioned place preference and reduces activation of the patch compartment.
Horner KA; Logan MC; Fisher TJ; Logue JB
Eur J Pharmacol; 2017 Feb; 796():207-214. PubMed ID: 28057490
[TBL] [Abstract][Full Text] [Related]
8. A role for mu opioid receptors in cocaine-induced activity, sensitization, and reward in the rat.
Schroeder JA; Hummel M; Simpson AD; Sheikh R; Soderman AR; Unterwald EM
Psychopharmacology (Berl); 2007 Dec; 195(2):265-72. PubMed ID: 17687547
[TBL] [Abstract][Full Text] [Related]
9. Compulsive Seekers: Our take. Two Clinicians' Perspective on a New Animal Model of Addiction.
Epstein DH; Kowalczyk WJ
Neuropsychopharmacology; 2018 Mar; 43(4):677-679. PubMed ID: 28653664
[No Abstract] [Full Text] [Related]
10. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
Koob GF
Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
[TBL] [Abstract][Full Text] [Related]
11. Accumbal μ-Opioid Receptors Modulate Ethanol Intake in Alcohol-Preferring Alko Alcohol Rats.
Uhari-Väänänen J; Raasmaja A; Bäckström P; Oinio V; Airavaara M; Piepponen P; Kiianmaa K
Alcohol Clin Exp Res; 2016 Oct; 40(10):2114-2123. PubMed ID: 27508965
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans.
Weber SC; Beck-Schimmer B; Kajdi ME; Müller D; Tobler PN; Quednow BB
Transl Psychiatry; 2016 Jul; 6(7):e850. PubMed ID: 27378550
[TBL] [Abstract][Full Text] [Related]
13. Multiple-dose safety, pharmacokinetics, and pharmacodynamics of the μ-opioid receptor inverse agonist GSK1521498.
Nathan PJ; Bush MA; Tao WX; Koch A; Davies KM; Maltby K; O'Neill BV; Napolitano A; Skeggs AL; Brooke AC; Richards DB; Williams PM; Bullmore ET
J Clin Pharmacol; 2012 Oct; 52(10):1456-67. PubMed ID: 22162534
[TBL] [Abstract][Full Text] [Related]
14. Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain.
Ortega-Alvaro A; Acebes I; Saracíbar G; Echevarría E; Casis L; Micó JA
Psychopharmacology (Berl); 2004 Nov; 176(3-4):305-11. PubMed ID: 15138764
[TBL] [Abstract][Full Text] [Related]
15. The opioid systems--panacea and nemesis.
Terenius L; Johansson B
Biochem Biophys Res Commun; 2010 May; 396(1):140-2. PubMed ID: 20494127
[TBL] [Abstract][Full Text] [Related]
16. The role of the subthalamic nucleus in 'compulsive' behavior in rats.
Winter C; Flash S; Klavir O; Klein J; Sohr R; Joel D
Eur J Neurosci; 2008 Apr; 27(8):1902-11. PubMed ID: 18412611
[TBL] [Abstract][Full Text] [Related]
17. Neurobiology of Compulsive Sexual Behavior: Emerging Science.
Kraus SW; Voon V; Potenza MN
Neuropsychopharmacology; 2016 Jan; 41(1):385-6. PubMed ID: 26657963
[No Abstract] [Full Text] [Related]
18. Discovery, stereospecific characterization and peripheral modification of 1-(pyrrolidin-1-ylmethyl)-2-[(6-chloro-3-oxo-indan)-formyl]-1,2,3,4-tetrahydroisoquinolines as novel selective κ opioid receptor agonists.
Gan ZJ; Wang YH; Xu YG; Guo T; Wang J; Song Q; Xu XJ; Hu SY; Wang YJ; Wang DC; Sun DZ; Zhang D; Xi T; Li HD; Zhang HB; Hang TJ; Lu HG; Liu JG
Org Biomol Chem; 2015 May; 13(20):5656-73. PubMed ID: 25895552
[TBL] [Abstract][Full Text] [Related]
19. The μ-opioid receptor and treatment response to naltrexone.
Thorsell A
Alcohol Alcohol; 2013; 48(4):402-8. PubMed ID: 23543091
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].
Kato H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Oct; 43(5):697-704. PubMed ID: 19068776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
